Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

From Genome to Drugs: New Approaches in Antimicrobial Discovery

9 Jun 2021

Abstract excerpt

Decades of successful use of antibiotics is currently challenged by the emergence of increasingly resistant bacterial strains. Novel drugs are urgently required but, in a scenario where private investment in the development of new antimicrobials is declining, efforts to combat drug-resistant infections become a worldwide public health problem. Reasons behind unsuccessful new antimicrobial development projects...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biosimilars and Bioanalytical Methods
Share to Biotechnology and Related Fields
Share to Transgenic Plants and Applications

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34177572
DOI: 10.3389/fphar.2021.647060

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

From Genome to Drugs: New Approaches in Antimicrobial DiscoveryPMID 34177572Read ↗

Genomic and functional techniques to mine the microbiome for novel antimicrobials and antimicrobial resistance genesSemantic proximity Read ↗

Harnessing the Power of the Genome in the Search for New AntibioticsSemantic proximity Read ↗

Computational biology: Role and scope in taming antimicrobial resistance.Semantic proximity Read ↗

A review on the diversity of antimicrobial peptides and genome mining strategies for their predictionSemantic proximity Read ↗

Development of Antimicrobial Agents in the Era of New and Reemerging Infectious Diseases and Increasing Antibiotic ResistanceSemantic proximity Read ↗

Mitigating the Impact of Antibacterial Drug Resistance through Host-Directed Therapies: Current Progress, Outlook, and ChallengesSemantic proximity Read ↗

Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomicsSemantic proximity Read ↗

Host-Directed Drug Targeting of Factors Hijacked by PathogensSemantic proximity Read ↗

Blanket antimicrobial resistance gene database with structural information, BOARDS, provides insights on historical landscape of resistance prevalence and effects of mutations in enzyme structure.Semantic proximity Read ↗

The role of genomics in the discovery of novel targets for antibiotic therapy.Semantic proximity Read ↗

Leveraging Vet-LIRN AMR data from USA to identify potential drug targets in imipenem-resistant E. coli isolates using interactive GIS dashboards, genomic analysis, subtractive genomics, and druggability assessmentSemantic proximity Read ↗

Genomics and Antimicrobial Drug DiscoverySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.